Related references
Note: Only part of the references are listed.Reviewing the effects of thiazide and thiazide-like diuretics as photosensitizing drugs on the risk of skin cancer
Reinhold Kreutz et al.
JOURNAL OF HYPERTENSION (2019)
Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC)
Kazem Rahimi et al.
BMJ OPEN (2019)
Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies
Aristeidis Seretis et al.
SCIENTIFIC REPORTS (2019)
An overview of methods for network meta-analysis using individual participant data: when do benefits arise?
Thomas P. A. Debray et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2018)
Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis
Sara Gandini et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta-analysis of observational studies
Huilin Tang et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2018)
Antihypertensive drugs use and the risk of prostate cancer: a meta-analysis of 21 observational studies
Liang Cao et al.
BMC UROLOGY (2018)
Individual participant data meta-analysis of continuous outcomes: A comparison of approaches for specifying and estimating one-stage models
Amardeep Legha et al.
STATISTICS IN MEDICINE (2018)
Antihypertensive drug use and breast cancer risk: a meta-analysis of observational studies
Haibo Ni et al.
ONCOTARGET (2017)
Bayesian one-step IPD network meta-analysis of time-to-event data using Royston-Parmar models
Suzanne C. Freeman et al.
RESEARCH SYNTHESIS METHODS (2017)
Introduction to the Analysis of Survival Data in the Presence of Competing Risks
Peter C. Austin et al.
CIRCULATION (2016)
Long term antihypertensive drug use and prostate cancer risk: A 9-year population-based cohort analysis
Pei-Ying Pai et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Get real in individual participant data (IPD) meta-analysis: a review of the methodology
Thomas P. A. Debray et al.
RESEARCH SYNTHESIS METHODS (2015)
Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial
Toshio Ogihara et al.
JOURNAL OF HYPERTENSION (2014)
An FDA overview of rodent carcinogenicity studies of angiotensin II AT-1 receptor blockers: Pulmonary adenomas and carcinomas
William T. Link et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2014)
Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure
Kei Asayama et al.
HYPERTENSION RESEARCH (2012)
Lay perspectives on hypertension and drug adherence: systematic review of qualitative research
Iain J. Marshall et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals The ARB Trialists Collaboration
Koon K. Teo et al.
JOURNAL OF HYPERTENSION (2011)
Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial
Masunori Matsuzaki et al.
JOURNAL OF HYPERTENSION (2011)
Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324168 participants from randomised trials
Sripal Bangalore et al.
LANCET ONCOLOGY (2011)
Irbesartan in Patients with Atrial Fibrillation
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials
Kazem Rahimi et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials
Iike Sipahi et al.
LANCET ONCOLOGY (2010)
The renin-angiotensin system and cancer: old dog, new tricks
Amee J. George et al.
NATURE REVIEWS CANCER (2010)
Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs
Janice Pogue et al.
CLINICAL TRIALS (2009)
Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE)
Hiroshi Kasanuki et al.
EUROPEAN HEART JOURNAL (2009)
Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients
Toshio Ogihara et al.
HYPERTENSION RESEARCH (2009)
ETS-1 AND HYPOXIA INDUCIBLE FACTOR-1 a INDUCED BY ANGIOTENSIN II: NOVEL NEW MOLECULAR TARGETS OF ANGIOTENSINII TYPE-1 RECEPTOR BLOCKER (ARB) AS AN ANGIOGENIC INHIBITOR.
Takeo Kosaka et al.
JOURNAL OF UROLOGY (2009)
Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks - Candesartan Antihypertensive Survival Evaluation in Japan Trial
Toshio Ogihara et al.
HYPERTENSION (2008)
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
S. Yusuf et al.
LANCET (2008)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Telmisartan to prevent recurrent stroke and cardiovascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: The prevention regimen for effectively avoiding second strokes trial (PRoFESS)
Hans-Christoph Diener et al.
CEREBROVASCULAR DISEASES (2007)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
B Dahlöf et al.
LANCET (2005)
Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention -: Principal results of a prospective randomized controlled study (MOSES)
J Schrader et al.
STROKE (2005)
Why hypertensive patients do not comply with the treatment
JJ Gascón et al.
FAMILY PRACTICE (2004)
Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: The Japan Multicenter investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial
Y Yui et al.
HYPERTENSION RESEARCH (2004)
Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating Telmisartan, Ramipril, and their combination in high-risk patients: The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials
KK Teo
AMERICAN HEART JOURNAL (2004)
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure the CAMELOT study: A randomized controlled trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
S Julius et al.
LANCET (2004)
Preventing microalbuminuria in type 2 diabetes
P Ruggenenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria
FW Asselbergs et al.
CIRCULATION (2004)
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease - The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial
CJ Pepine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Candesartan antihypertensive survival evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: Rationale, design, and methods
T Fukui et al.
HYPERTENSION RESEARCH (2003)
The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): Design and baseline characteristics
A Perna
CONTROLLED CLINICAL TRIALS (2003)
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK)
JJ Gassman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial
HR Black et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly
LMH Wing et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease - Results from the AASK trial
JT Wright et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Network meta-analysis for indirect treatment comparisons
T Lumley
STATISTICS IN MEDICINE (2002)
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
LH Lindholm et al.
LANCET (2002)
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian cardiac outcomes trial
PS Sever et al.
JOURNAL OF HYPERTENSION (2001)
The EUROPA trial: Design, baseline demography and status of the substudies
AH Gomma et al.
CARDIOVASCULAR DRUGS AND THERAPY (2001)
Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events
B Pitt et al.
CIRCULATION (2000)
Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease
S MacMahon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and Ramipril (DIABHYCAR) study:: Design, organization, and patient recruitment
M Lièvre et al.
CONTROLLED CLINICAL TRIALS (2000)
Share Paper
